BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17413173)

  • 1. Screening programmes for chlamydial infection: when will we ever learn?
    Low N
    BMJ; 2007 Apr; 334(7596):725-8. PubMed ID: 17413173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
    Nyári T; Mészáros G; Deák J; Nagy E; Kovács L
    Orv Hetil; 2000 Jul; 141(27):1511-6. PubMed ID: 10943109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chlamydia problem in New Zealand.
    Perkins N
    N Z Med J; 2004 May; 117(1194):U887. PubMed ID: 15156205
    [No Abstract]   [Full Text] [Related]  

  • 4. [Screening for Chlamydia trachomatis infection: which target group and at what price?].
    Postma MJ; van den Hoek JA
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1237-8. PubMed ID: 10428675
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics.
    Mayaud P; Grosskurth H; Changalucha J; Todd J; West B; Gabone R; Senkoro K; Rusizoka M; Laga M; Hayes R
    Bull World Health Organ; 1995; 73(5):621-30. PubMed ID: 8846488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding efforts to prevent chlamydial infection.
    Stamm WE
    N Engl J Med; 1998 Sep; 339(11):768-70. PubMed ID: 9731096
    [No Abstract]   [Full Text] [Related]  

  • 7. Is Europe ready for STD screening?
    Mårdh PA
    Genitourin Med; 1997 Apr; 73(2):96-8. PubMed ID: 9215088
    [No Abstract]   [Full Text] [Related]  

  • 8. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN
    Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for Chlamydia trachomatis.
    Jones R; Boag F
    BMJ; 2007 Apr; 334(7596):703-4. PubMed ID: 17413140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective screening for chlamydial infection in women: a comparison of three sets of criteria.
    Marrazzo JM; Fine D; Celum CL; DeLisle S; Handsfield HH
    Fam Plann Perspect; 1997; 29(4):158-62. PubMed ID: 9258646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis infections in female military recruits.
    Gaydos CA; Howell MR; Pare B; Clark KL; Ellis DA; Hendrix RM; Gaydos JC; McKee KT; Quinn TC
    N Engl J Med; 1998 Sep; 339(11):739-44. PubMed ID: 9731090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis genital infections--United States, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(9):193-8. PubMed ID: 9072679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Chlamydia trachomatis. Screening for and treatment of chlamydial infection demand commitment.
    Opaneye AA
    BMJ; 1998 Sep; 317(7159):682. PubMed ID: 9758504
    [No Abstract]   [Full Text] [Related]  

  • 14. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
    Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening.
    LaMontagne DS; Fenton KA; Randall S; Anderson S; Carter P
    Sex Transm Infect; 2004 Oct; 80(5):335-41. PubMed ID: 15459399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia trachomatis: common misperceptions and misunderstandings.
    Stevens-Simon C; Sheeder J
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):231-43. PubMed ID: 16171726
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlamydia trachomatis during pregnancy. To screen or not to screen?
    Carroll JC
    Can Fam Physician; 1993 Jan; 39():97-102. PubMed ID: 8435566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Habets PC
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):499-501. PubMed ID: 11268916
    [No Abstract]   [Full Text] [Related]  

  • 19. [Towards screening for Chlamydia trachomatis].
    Kolmos HJ
    Ugeskr Laeger; 1997 Aug; 159(34):5104-5. PubMed ID: 9297316
    [No Abstract]   [Full Text] [Related]  

  • 20. [Screening for Chlamydia trachomatis infection: which group should be targeted and at what price?].
    van Vloten WA
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):652-3. PubMed ID: 10321294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.